Immunization of Colorectal carcinoma patients with a recombinant canarypox virus expressing the tumor antigen Ep-CAM/KSA (ALVAC-KSA) and granulocyte macrophage colony-stimulating factor induced a tumor-specific cellular immune responses

Saved in:
Bibliographic Details
Published inClinical cancer research Vol. 9; no. 7; pp. 2447 - 2456
Main Authors ULLENHAG, Gustav J, FRÖDIN, Jan-Erik, MOSOLITS, Szilvia, KIAII, Shahryar, HASSAN, Moustapha, BONNET, Marie Claude, MOINGEON, Philippe, MELLSTEDT, Hakan, RABBANI, Hodjattallah
Format Journal Article
LanguageEnglish
Published Philadelphia, PA American Association for Cancer Research 2003
Subjects
Antineoplastic agents
Biological and medical sciences
Immunotherapy
Medical sciences
Pharmacology. Drug treatments
Antineoplastic agent
Rectal disease
Carcinoma
Recombinant virus
Vaccination
Cellular immunity
Immunotherapy
T-Lymphocyte
Intestinal disease
Colon
Vector
Human
Antigen presentation
Chordopoxvirinae
Drug combination
Immunization
Immune response
Tumor associated antigen
Cell adhesion molecule
Malignant tumor
Gene expression
Colonic disease
Virus
Avipoxvirus
Treatment
Poxviridae
Rectum
Digestive diseases
Granulocyte macrophage colony stimulating factor
Online AccessGet full text

Cover

More Information
ISSN:1078-0432
1557-3265